medisourceasia.com

Industry News


Home

About 
medisourceasia

Magazine
Industry News
Global Trends
Events Calendar
Web Links

Web Gallery

Advertising  Info

Contact

 

Industry Wants ICMED Certification Mandatory For All Medical Devices Marketed In India

Experts have urged the Centre to make Indian Certification of Medical Devices Scheme (ICMED), country’s first indigenously developed quality assurance system for medical devices mandatory for all medical devices marketed in the country. This was proposed in recently concluded meeting called to draft (separate) rules for medical devices with the top government officials with special focus on drafting regulatory framework for granting manufacturing licenses for medical devices.

The meeting stressed upon the need for registration of low risk and moderate risk devices on basis of 3rd Party (CAB) certification and grant of manufacturing license to high risk device manufacturers and importers on basis of defined criteria and inspection. This according to sources will be done by CDSCO medical devices officers with a predefined competency or through 3rd party certification bodies.

Association of Indian Medical Devices Industry (AIMED) strongly advocated that ICMED certification should be made mandatory as the scheme will be able to fill big regulatory vacuum in quality certification space for medical devices in the country and will enhance the competitiveness and profitability of Indian medical device industry. Currently, there is no India-specific official quality assurance system, due to which Indian medical device manufacturers encountered loss of competitiveness to foreign companies while consumers ended up paying extra premium with no concomitant benefits, ICMED also fills a big regulatory void.

Launched in March, ICMED has two certification options, ICMED 9000 certification (an ISO 9001 plus additional requirements) for low risk medical devices and ICMED 13485 (An ISO 13485 plus additional requirements) for medium and higher risk devices. A third level, to additionally prescribe medical device specifications developed by health ministries NHSRC is still under development and would be launched later this year.

“Why not make ICMED certification mandatory, as it is aimed at enhancing patient safety, provide enhanced consumer protection along with much needed product credentials to manufacturers for instilling confidence among buyers and users. This Scheme is intended to significantly eliminate trading of sub-standard products or devices of doubtful origins, a widespread and injurious phenomenon in the Indian market. Most importantly, it will bring down the substantial time and cost-run to obtain globally accepted quality certification for Indian companies, thereby ensuring substantial savings, enhanced credibility,” stressed Rajiv Nath, forum coordinator, AIMED and chairman, technical committee, QCI-AIMED.

ICMED is the first home developed international class certification scheme for the medical devices in the country. It is a joint initiative of AIMED, Quality Council of India (QCI) and the National Accreditation Board for Certification Bodies (NABCB).

(Ref.: http://www.pharmabiz.com/NewsDetails.aspx?aid=95101&sid=1)


India And Japan To Seek Regulatory Collaboration For Medical Products

The Japan has extended support to Government of India for Indian regulators’ skill enhancement through its Asia Training Centre.

India and Japan are looking to accelerate collaboration for medical products through increased collaboration between the regulators of the two countries. Against this background, the first ever joint symposium between India and Japan to facilitate regulatory collaboration for medical products was organised by FICCI from May 18-19, 2016 in New Delhi.

As India is scaling up its healthcare systems and in parallel streamlining the pharmaceutical and medical devices regulatory guidelines, it is envisaged that harmonisation of regulatory frameworks will benefit trade exchange & technology exchange for larger good. Japan is the third largest medical devices manufacturer and consumer in the world. It is a pioneer for development of several pharmaceutical and medical devices.

Japan and India are strong cultural and trade partners, with Japan being the fourth largest FDI contributor to India. Under the agreement held in 2015 between PM Narendra Modi and Japanese PM Shinzo Abe, FDIs from Japan are likely to be doubled by 2019.

During the two day symposium, participants from both countries agreed to collaborate more comprehensively in future. The Japanese side has extended support to Government of India for Indian regulators’ skill enhancement through its Asia Training Centre.

This is a great start. We have achieved much needed momentum for our regulators to meet and collaborate. From this point onwards, we collectively commit ourselves to greater partnership and bilateral relationship”, said Probir Das, chairman, FICCI Medical Devices Forum.

(Ref.: http://www.businessstandard.com/content/b2b-pharma/indiaand-japan-to-seek-regulatory-collaboration-for-medical-products-116052100319_1.html)

Other News

Andhra Med Tech Zone Gets Formal Registration To Set Up Asia’s First Dedicated Medical Devices Park
Gujarat Govt Allocates Land For Setting Up Medical Device Park At Sanand
Separate Rules To Spur Medical Devices Sector Soon
Centre To Notify Revised Schedule M III For Medical Devices By June End

Archives

Advertisement

 

 


Back | Back To Top | Previous | Next